Vitrigold Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 06-07-2024
- Paid Up Capital ₹ 3.00 M
as on 06-07-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.13 Cr
as on 06-07-2024
- Satisfied Charges ₹ 2.85 Cr
as on 06-07-2024
- Revenue -44.44%
(FY 2022)
- Profit 96.26%
(FY 2022)
- Ebitda 43.58%
(FY 2022)
- Net Worth 3.00%
(FY 2022)
- Total Assets 8.49%
(FY 2022)
About Vitrigold Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹2.13 Cr. The company has closed loans amounting to ₹2.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pushpaben Patel, Bharatbhai Patel, Sanjaykumar Rabari, and One other member serve as directors at the Company.
- CIN/LLPIN
U01132GJ2015PTC082181
- Company No.
082181
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2015
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Anand, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vitrigold Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pushpaben Patel  | Director | 09-Feb-2015 | Current |
| Bharatbhai Patel | Director | 09-Feb-2015 | Current |
| Sanjaykumar Rabari | Director | 09-Feb-2015 | Current |
| Manharsinh Parmar | Director | 09-Feb-2015 | Current |
Financial Performance of Vitrigold Biotech.
Vitrigold Biotech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 44.44% decrease. The company also saw a substantial improvement in profitability, with a 96.26% increase in profit. The company's net worth moved up by a moderate rise of 3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vitrigold Biotech?
In 2021, Vitrigold Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saburi Bio Tech Private LimitedActive 14 years 8 monthsBharatbhai Patel, Sanjaykumar Rabari and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 May 2020 | ₹0.50 M | Open |
Others Creation Date: 14 Sep 2018 | ₹8.13 M | Open |
Others Creation Date: 12 Sep 2018 | ₹1.27 Cr | Open |
How Many Employees Work at Vitrigold Biotech?
Unlock and access historical data on people associated with Vitrigold Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vitrigold Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vitrigold Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
